"One size fits all" approach is not suitable for cancer treatment, because there are many different types of tumors, and some of these people don't understand.Imaging techniques can help us to study the mechanism and treatment of tumor progression.
There have been great progress in recent years, the cancer treatment;However, there are still not well understood, some tumor types of existing treatments have no positive feedback.In addition, there are many cases in the treatment of incurable diseases, or cause serious side effects.Research, therefore, continue to find new methods of cancer treatment, and to develop better ways in view of the current treatment methods.In tumor imaging technology continues to play a key role in this research work.
Noninvasive imaging provides the tumor development, key insights for the treatment of response and drug toxicity.Through a combination of structural and functional imaging mode, can further improve the strategy analysis of the value of a single imaging.In preclinical studies using in vivo imaging of multimodal imaging, cancer can be real-time observed the process of long duration, high sensitivity, high resolution.Through the use of various imaging techniques, including MRI, SPECT, PET and CT and micro - CT, people have a deeper understanding about a series of tumor and to improve the treatment plan.
Brooke provide a comprehensive range of innovative noninvasive in vivo imaging technology, to promote the process of tumor progression and the mechanism and treatment effect.Dual mode imaging configuration, such as PET/CT and PET/MR, even in combination with the technology of PET, SPECT and CT three patterns of instrument, can meet the research needs of today's most challenging, and provide the radioactive substances, bone and soft tissue quantitative three-dimensional CT image.